Dr. Young Thi Mcmahan, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Richland West Cir Ste 2c, Waco, TX 76712 Phone: 254-340-6000 |
Dr. Jeannie Mai Nguyen, M.D., M.S. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 7700 Fish Pond Rd, Waco, TX 76710 Phone: 254-761-4444 Fax: 254-761-4441 |
Joseph E Knipper, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 601 W State Highway 6, Suite 103, Waco, TX 76710 Phone: 254-751-9040 Fax: 254-751-9018 |
Gregory Walker, M.D., M.B.A. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 300 Richland West Cir Ste 2c, Waco, TX 76712 Phone: 254-340-6000 Fax: 254-340-6010 |
Mark Franklin Naylor, MD Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 7700 Fish Pond Rd, Waco, TX 76710 Phone: 254-761-4444 |
Michael Martin Hatch, M.D. Dermatology - Dermatopathology Medicare: Accepting Medicare Assignments Practice Location: 7106 Sanger Rd, Waco, TX 76712 Phone: 542-537-1265 |
News Archive
IntegraMed America, Inc., the nation's leading manager of specialty outpatient healthcare facilities in the emerging, technology-focused medical niches of fertility and vein care, today reported improved overall operating results for the third quarter and nine months ended September 30, 2009.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that thought leaders believe Prometheus's Lotronex has efficacy advantages over current and emerging therapies for non-constipation predominant irritable bowel syndrome but side effects associated with the drug limit its use.
Compared with erlotinib, treatment with afatinib leads to outcomes in previously treated patients with advanced squamous non-small-cell lung cancer, suggest the results of a head-to-head trial.
More and more men who believe they have low-risk prostate cancers are opting for active surveillance, forgoing treatment and monitoring the cancer closely with prostate-specific antigen (PSA) tests, digital rectal exams and ultrasounds at regular intervals to see if their tumors are growing. Nearly 400 men are now enrolled in the UCLA Active Surveillance program, the largest in Southern California.
A group of Swiss researchers headed by Prof. Sylvia Schneider has published a groundbreaking study on treatment of separation anxiety in the current issue of Psychotherapy and Psychosomatics.
› Verified 2 days ago